In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end …

The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady,
predictable decline in lung function over time. Recent evidence suggests that some …

Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …

Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS)
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …

With more than 900 000 confirmed cases worldwide and nearly 50 000 deaths during the
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …

Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …

… The views and interests of the ATS, ERS, JRS, and ALAT, as well as of any commercial
entity that provided external funding for professional societies, had no influence on the topics …

… Correspondence and requests for reprints should be addressed to Athol U. Wells, MD,
Interstitial Lung Disease Unit, Royal Brompton Hospital and NHLI, Imperial College, Emmanuel …

… Several rare variants of the genes TERT (encoding telomerase reverse transcriptase) and
TERC (encoding telomerase RNA component) as well as of other genes related with telomere …